Safety, immunogenicity, and lot-to-lot consistency of a split-virion quadrivalent influenza vaccine in younger and older adults: A phase III randomized, double-blind clinical trial

Here, we report a randomized multicenter phase III trial assessing the lot-to-lot consistency of the 2014–2015 Northern Hemisphere quadrivalent split-virion inactivated influenza vaccine (IIV4; Sanofi Pasteur) and comparing its immunogenicity and safety with that of trivalent inactivated influenza v...

Descripción completa

Detalles Bibliográficos
Autores principales: Sesay, Sanie, Brzostek, Jerzy, Meyer, Ingo, Donazzolo, Yves, Leroux-Roels, Geert, Rouzier, Régine, Astruc, Béatrice, Szymanski, Henryk, Toursarkissian, Nicole, Vandermeulen, Corinne, Kowalska, Edyta, Van Damme, Pierre, Salamand, Camille, Pepin, Stephanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861783/
https://www.ncbi.nlm.nih.gov/pubmed/28968138
http://dx.doi.org/10.1080/21645515.2017.1384106

Ejemplares similares

Ejemplares similares